Expertise in
8
conditions

Meg J. Jardine

Camperdown, NSW, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Camperdown, NSW, AU 
OverviewLocationsClinical Research

Overview

Meg Jardine practices in Camperdown, Australia. Ms. Jardine is highly rated in 8 conditions, according to our data. Her top areas of expertise are Type 2 Diabetes (T2D), Chronic Kidney Disease, Diabetic Nephropathy, Wilson Disease, and Kidney Transplant.

Her clinical research consists of co-authoring 235 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Camperdown, NSW, Australia
Other Locations
Sydney, NSW, Australia
Syndey, Australia
Camperdown, VIC, Australia
Concord, NSW, Australia
Newtown, NSW, Australia
The Royal North Shore Hospital, Royal North Shore Hospital, St. Leonards, North Shore, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Enrollment Status: Recruiting
Publish Date: April 04, 2025
Intervention Type: Other
Study Phase: Phase 4
Global Kidney Patient Trials Network
Global Kidney Patient Trials Network
Enrollment Status: Active_not_recruiting
Publish Date: September 12, 2025
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
Enrollment Status: Active_not_recruiting
Publish Date: June 12, 2025
Intervention Type: Drug
Study Drugs: Sparsentan, Irbesartan
Study Phase: Phase 3
View 2 Less Clinical Trial

235 Total Publications

Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset.
Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset.
Journal: BMJ open
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jardine's expertise for a condition
ConditionClose
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile